Functional and molecular imaging modalities are state-of-art technologies for in vivo assessment of pathology, and important tools in basic medical research. Nuclear medicine can facilitate early diagnosis and evaluation of therapy response. Especially, molecular radionuclide therapy allows for quantitative theranostic imaging and dose-effect evaluation.
The group collaborates closely with the Department for Nuclear Medicine in establishing novel methods and radiopharmaceuticals. Due to the recent advancement in nuclear medicine technology, medical physics play a significant role in the cross-disciplinary research team. The research group is responsible for quantitative measurements and advanced image analyses in various clinical studies.
The group focuses on
- Dosimetry and treatment planning for molecular radiotherapies (theranostics)
- Quantitative PET and SPECT imaging and pharmacokinetic modelling
- Implementation of novel methods and processing techniques for nuclear medicine imaging